134 related articles for article (PubMed ID: 17695469)
21. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
22. [Immunostimulatory properties of mistletoe extracts and their application in oncology].
Wrotek S; Skawiński R; Kozak W
Postepy Hig Med Dosw (Online); 2014 Oct; 68():1216-24. PubMed ID: 25380204
[TBL] [Abstract][Full Text] [Related]
23. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
[TBL] [Abstract][Full Text] [Related]
24. Prevention of surgery-induced suppression of granulocyte function by intravenous application of a fermented extract from Viscum album L. in breast cancer patients.
Büssing A; Bischof M; Hatzmann W; Bartsch F; Soto-Vera D; Fronk EM; Gmeindl M; Stein GM
Anticancer Res; 2005; 25(6C):4753-7. PubMed ID: 16334172
[TBL] [Abstract][Full Text] [Related]
25. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
26. Effects of Viscum album L. on cyclophosphamide-treated peripheral blood mononuclear cells in vitro: sister chromatid exchanges and activation/proliferation marker expression.
Büssing A; Regnery A; Schweizer K
Cancer Lett; 1995 Aug; 94(2):199-205. PubMed ID: 7634248
[TBL] [Abstract][Full Text] [Related]
27. Natural killer and antibody-dependent cell-mediated cytotoxicity activities and large granular lymphocyte frequencies in Viscum album-treated breast cancer patients.
Hajto T; Lanzrein C
Oncology; 1986; 43(2):93-7. PubMed ID: 3951791
[TBL] [Abstract][Full Text] [Related]
28. Immunomodulatory effects of iscador: a Viscum album preparation.
Hajto T
Oncology; 1986; 43 Suppl 1():51-65. PubMed ID: 2433654
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
Cebović T; Spasić S; Popović M
Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
[TBL] [Abstract][Full Text] [Related]
30. Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.
Schad F; Axtner J; Kröz M; Matthes H; Steele ML
Integr Cancer Ther; 2018 Mar; 17(1):41-51. PubMed ID: 29444603
[TBL] [Abstract][Full Text] [Related]
31. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
[TBL] [Abstract][Full Text] [Related]
32. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
Kirsch A; Hajto T
J Altern Complement Med; 2011 Oct; 17(10):973-9. PubMed ID: 22010781
[TBL] [Abstract][Full Text] [Related]
33. Effects of mistletoe extract on murine thymocytes in vivo and on glucocorticoid-induced cell count reduction.
Hajtó T; Berki T; Pálinkás L; Boldizsár F; Németh P
Forsch Komplementmed; 2006 Feb; 13(1):22-7. PubMed ID: 16582547
[TBL] [Abstract][Full Text] [Related]
34. Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.
Heinzerling L; von Baehr V; Liebenthal C; von Baehr R; Volk HD
J Clin Immunol; 2006 Jul; 26(4):347-59. PubMed ID: 16705487
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.
Elluru S; Duong Van Huyen JP; Delignat S; Prost F; Bayry J; Kazatchkine MD; Kaveri SV
Arzneimittelforschung; 2006 Jun; 56(6A):461-6. PubMed ID: 16927527
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.
Büssing A; Suzart K; Bergmann J; Pfüller U; Schietzel M; Schweizer K
Cancer Lett; 1996 Jan; 99(1):59-72. PubMed ID: 8564930
[TBL] [Abstract][Full Text] [Related]
38. Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer.
Axtner J; Steele M; Kröz M; Spahn G; Matthes H; Schad F
BMC Cancer; 2016 Aug; 16():579. PubMed ID: 27485618
[TBL] [Abstract][Full Text] [Related]
39. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
Stein G; Berg PA
Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
[TBL] [Abstract][Full Text] [Related]
40. Viscum album L. Therapy in Oncology: An Update on Current Evidence.
Thronicke A; Schad F; Debus M; Grabowski J; Soldner G
Complement Med Res; 2022; 29(4):362-368. PubMed ID: 35325897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
